Hangzhou DAC Biotechnology Co., Ltd.
PrivateLast Round
Strategic
Jun 1, 2022
Est. Valuation
$52.25M
Total Funding Raised
$322.77M
Company Overview
Hangzhou DAC Biotechnology Co., Ltd. is a biopharmaceutical company that specializes in the research, development, and production of monoclonal antibody-drug conjugates (ADCs) for the treatment of advanced cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou DAC Biotechnology Co., Ltd. Comparables
Compare Hangzhou DAC Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MediLink Therapeutics | 85% | |
| Duality Biotherapeutics Inc | 84% | |
| Kelun-Biotech | 81% | |
Hangzhou DAC Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jun 1, 2022 | ||||
| Series C | May 10, 2021 | ||||
| Series C | Mar 1, 2021 | ||||
| Series B | Sep 1, 2019 | ||||
| Series A | May 1, 2017 | ||||
Pre Seed | Nov 27, 2015 |
Hangzhou DAC Biotechnology Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 中信金石投资有限公司 | Series C |
| ZJKF Capital Management | Pre Seed |
| Hillhouse Investment | Series C |
| CITIC Securities Company Limited | Series C |
| CITIC Securities | Series C |
| China International Capital Corporation | Series C |
| Chenling Capital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2022
Led by Johnson & Johnson Innovation - JJDC, Inc.
- May 10, 2021
$156M round led by CDG Capital and Chenling Capital.
Hangzhou DAC Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Hangzhou DAC Biotechnology Co., Ltd.'s valuation, stock price, and market status.